Stuttering Clinical Trial
Official title:
The Effect of Spacing of Lidcombe Program Clinic Visits
The purpose of this study is to evaluate the efficiency of the Lidcombe Program for early stuttering by varying the time between clinic visits during the first stage of the program.
Stuttering is a communicative disorder that affects an estimated 5.19% of children. Although
approximately 71.4% of children whose stuttering onset is in the preschool years exhibit
spontaneous recovery within two years after first reported onset, there remain a significant
number of children who require fluency intervention. Given the potential for negative long
term social and communicative consequences due to persistent stuttering, there is a
consensus among speech-language pathologists that stuttering should be treated early.
However, the longer a child's stuttering persists, the less likely the child will
spontaneously recover.
The Lidcombe Program is a behavioral therapy program for preschool children designed to
treat stuttering at its early stages. The treatment approach involves the direct
participation of parents, who are trained during parent and child weekly visits to a speech
language pathologist. In the first stage of the program, the clinician demonstrates the
therapy to the parent, observes the parent conduct therapy and provides feedback and goals
for the following week until the next clinic visit. The clinician guides the parent to
provide three types of verbal "reinforcement" contingencies for the child's stutter free
speech. These include, acknowledgment, praise and request for self-evaluation, where the
child is asked to recognize his or her stutter free speech. If unambiguous stuttering
occurs, the parent provides two types of verbal "punishment" contingencies including
acknowledgment of the stuttering and request for self-correction, where the child is asked
to repeat the stuttered word again. These contingencies are administered by parents in
everyday speaking conversations, in order to promote generalization of fluent speech. When
the child's stuttering is reduced to near-zero levels, the child then enters the second
stage of the program, where the number of clinic visits are gradually phased out from
bi-monthly to monthly to every 2 months, and so on, as required by the child. The purpose of
the stage 2 visits is for the speech language pathologist to evaluate the child's speech and
to ensure that near-zero stuttering levels are maintained.
When the first stage of the Lidcombe program is followed as the program was originally
designed, the median treatment time to achieve the criteria of near-zero levels of
stuttering is 11 one-hour weekly clinic visits, with treatment times varying according to
the severity of the stuttering. However, clinicians have been deviating from the standard
weekly sessions for various reasons. For instance, some private practitioners are offering
first stage treatment visits once every 2 weeks rather than weekly and other practitioners
are offering treatment intensively, so that clients from remote areas can have access to the
Lidcombe program. As yet, there are no data to confirm whether treatment using fortnightly
or twice weekly clinic visits is as effective or efficient as the standard weekly visits.
The aim of this project is to evaluate the following questions: (1) Does altering the
spacing of LP clinic visits affect treatment efficiency? (2) Does altering the spacing of LP
clinic visits affect treatment efficacy?
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Health Services Research
Status | Clinical Trial | Phase | |
---|---|---|---|
Suspended |
NCT01684657 -
A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering
|
Phase 3 | |
Not yet recruiting |
NCT05437627 -
Computerized Based Analysis for Detection and Severity Assessment of Stuttering
|
||
Completed |
NCT02288598 -
Enhancing Speech Fluency With Non-invasive Brain Stimulation in Developmental Stuttering
|
N/A | |
Completed |
NCT00001602 -
Genetic Factors Related to Stuttering
|
N/A | |
Active, not recruiting |
NCT04082104 -
Assessment of Stuttering Severity in Adults and Adolescences in Conversational and Narrative Contexts
|
||
Completed |
NCT04580966 -
IBSR Intervention for Adults Who Stutter
|
N/A | |
Recruiting |
NCT00148161 -
Activity of the Auditory Cortex During Speech Perception and Speech Production in Stuttering
|
N/A | |
Recruiting |
NCT05908123 -
Exploring the Nature, Assessment and Treatment of Stuttering
|
N/A | |
Completed |
NCT00001551 -
Characteristics of Idiopathic Familial Speech Disorders
|
N/A | |
Withdrawn |
NCT01315730 -
The Effects of Tactile Speech Feedback on Stuttering Frequency
|
Phase 1 | |
Completed |
NCT00004991 -
Study of Brain Activity During Speech Production and Speech Perception
|
N/A | |
Recruiting |
NCT05286151 -
Network Connectivity and Temporal Processing in Adolescents Who Stutter
|
N/A | |
Completed |
NCT00001604 -
Genetic Linkage Studies of Stuttering
|
||
Recruiting |
NCT00709072 -
Follow-up of Children After Stuttering Treatment
|
Phase 2 | |
Completed |
NCT00830154 -
A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering
|
Phase 2/Phase 3 | |
Completed |
NCT03698539 -
How Stuttering and Gestures Influence the Intelligibility of Individuals With Down Syndrome
|
||
Completed |
NCT04505696 -
Providing Speech Therapy Awareness in Private Schools
|
N/A | |
Recruiting |
NCT04929184 -
Speech Processing in Stuttering
|
N/A | |
Terminated |
NCT00001308 -
Central Mechanisms in Speech Motor Control Studied With H215O PET
|
||
Completed |
NCT01097161 -
Stuttering and Apraxia of Speech: the Efficacy of an Intervention Program
|
N/A |